T. Rowe Price Associates’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $69.3M | Buy |
|
|||||
|
2025
Q3 | $44.7M | Buy |
|
|||||
|
2025
Q2 | $18.5M | Buy |
|
|||||
|
2025
Q1 | $9.13M | Sell |
|
|||||
|
2024
Q4 | $16.1M | Sell |
|
|||||
|
2024
Q3 | $46.1M | Sell |
|
|||||
|
2024
Q2 | $49.8M | Buy |
|
|||||
|
2024
Q1 | $22M | Buy |
|
|||||
|
2023
Q4 | $21.7M | Buy |
|
|||||
|
2023
Q3 | $6.64M | Buy |
|
|||||
|
2023
Q2 | $1.34M | Buy |
|
|||||
|
2023
Q1 | $1.14M | Buy |
|
|||||
|
2022
Q4 | $896K | Buy |
|
|||||
|
2022
Q3 | $594K | Buy |
|
|||||
|
2022
Q2 | $265K | Buy |
|
|||||
|
2022
Q1 | $222K | Sell |
|
|||||
|
2021
Q4 | $3.57M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $6.7M | Sell |
|
|||||
|
2020
Q3 | $5.87M | Buy |
|
|||||
|
2020
Q2 | $7.63M | Sell |
|
|||||
|
2020
Q1 | $5.55M | Sell |
|
|||||
|
2019
Q4 | $9.92M | Buy |
|